StockData
Encompass Health Corp logo

Encompass Health Corp (EHC) stock

EHCNYSEServices-HospitalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 17/307% above fair value
$131.49+9.40 (+7.70%)

Close on Oct 29, 2026Market cap $12.97BP/E 21.4Yield 0.55%

Earnings

Encompass Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 4, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$1.61B
+8.9% on a year earlier
Adjusted earnings per share, Q3 FY2026
$1.52
$1.23 a year earlier
Latest guidance
Issued
Oct 28, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Encompass Health's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 4, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Oct 28, 2026after the close$1.61B+8.9%$1.51$1.52Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026during market hours––––Release
Q1 FY2026ended Mar 31, 2026Apr 30, 2026during market hours$1.59B+9.0%$1.77$1.60Release
Q4 FY2025ended Dec 31, 2025Feb 5, 2026during market hours$1.54B+9.9%$1.42$1.46Release
Q3 FY2025ended Sep 30, 2025Oct 29, 2025during market hours$1.48B+9.4%$1.24$1.23Release
Q2 FY2025ended Jun 30, 2025Aug 4, 2025during market hours$1.46B+12.0%$1.39$1.40Release
Q1 FY2025ended Mar 31, 2025Apr 24, 2025during market hours$1.46B+10.6%$1.48$1.37Release
Q4 FY2024ended Dec 31, 2024Feb 6, 2025during market hours$1.41B+12.7%$1.18$1.17Release
Q3 FY2024ended Sep 30, 2024Oct 28, 2024during market hours$1.35B+11.9%$1.07$1.03Release
Q2 FY2024ended Jun 30, 2024Aug 5, 2024during market hours$1.30B+9.6%$1.13$1.11Release
Q1 FY2024ended Mar 31, 2024Apr 24, 2024during market hours$1.32B+13.4%$1.11$1.12Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Encompass Health's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Net operating revenueGAAPFY2026$6.45B – $6.50B–NewOct 28, 2026
Net operating revenueFY2026$6.38B – $6.47B$6.37B – $6.47BRaisedApr 30, 2026
Adjusted EBITDAnon-GAAPFY2026$1.40B – $1.42B–NewOct 28, 2026
Adjusted EBITDAnon-GAAPFY2026$1.35B – $1.38B$1.34B – $1.38BRaisedApr 30, 2026
Adjusted earnings per share from continuing operations attributable to Encompass Healthnon-GAAPFY2026$6.23 – $6.37–NewOct 28, 2026
Adjusted earnings per share from continuing operations attributable to Encompass Healthnon-GAAPFY2026$5.89 – $6.11$5.81 – $6.10RaisedApr 30, 2026
Amortization of debt-related itemsGAAPFY2026$10.00M$10.00MLoweredAug 5, 2026
Interest expense and amortization of debt discounts and feesGAAPFY2026$130.00M$120.00MRaisedAug 5, 2026

Guidance vs results

The last range Encompass Health gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Adjusted earnings per share from continuing operations attributable to Encompass Health$5.22 – $5.37$5.46Σ4QAbove range
FY2025Revenue$5.91B – $5.96B$5.94BΣ4QWithin range

Guidance history

Every forecast Encompass Health put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Oct 28, 2026Adjusted EBITDAFY2026$1.40B – $1.42BNew
Oct 28, 2026Adjusted earnings per share from continuing operations attributable to Encompass HealthFY2026$6.23 – $6.37New
Oct 28, 2026Net operating revenueFY2026$6.45B – $6.50BNew
Aug 5, 2026Interest expense and amortization of debt discounts and feesFY2026$130.00MRaised
Aug 5, 2026Amortization of debt-related itemsFY2026$10.00MLowered
Apr 30, 2026Adjusted EBITDAFY2026$1.35B – $1.38BRaised
Apr 30, 2026Adjusted earnings per share from continuing operations attributable to Encompass HealthFY2026$5.89 – $6.11Raised
Apr 30, 2026Net operating revenueFY2026$6.38B – $6.47BRaised
Feb 5, 2026Adjusted EBITDAFY2026$1.34B – $1.38BNew
Feb 5, 2026Adjusted earnings per share from continuing operations attributable to Encompass HealthFY2026$5.81 – $6.10New
Feb 5, 2026Interest expense and amortization of debt discounts and feesFY2026$120.00MNew
Feb 5, 2026Amortization of debt-related itemsFY2026$10.00MLowered
Feb 5, 2026Net operating revenueFY2026$6.37B – $6.47BNew
Oct 29, 2025Adjusted EBITDAFY2025$1.24B – $1.26BRaised
Oct 29, 2025Adjusted earnings per share from continuing operations attributable to Encompass HealthFY2025$5.22 – $5.37Raised
Oct 29, 2025Interest expense and amortization of debt discounts and feesFY2025$125.00MNew
Oct 29, 2025Amortization of debt-related itemsFY2025$10.00MLowered
Oct 29, 2025Net operating revenueFY2025$5.91B – $5.96BNarrowed
Aug 4, 2025Adjusted EBITDAFY2025$1.22B – $1.25BNew
Aug 4, 2025Adjusted earnings per share from continuing operations attributable to Encompass HealthFY2025$5.12 – $5.34New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Encompass Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. Encompass Health reports results for third quarter 2026
    Results
  2. Quarterly results release
    Results
  3. Encompass Health reports results for second quarter 2026
    Results
  4. Quarterly results release
    Results
  5. Encompass Health announces pricing of $500 million of senior notes due 2034 in a private offering
    News
  6. Encompass Health reports results for first quarter 2026
    Results
  7. Quarterly results release
    Results
  8. Encompass Health reports results for fourth quarter 2025
    Results
  9. Quarterly results release
    Results
  10. Encompass Health reports results for third quarter 2025
    Results
  11. Quarterly results release
    Results
  12. Encompass Health reports results for second quarter 2025
    Results
  13. Quarterly results release
    Results
  14. Investor Reference Book Published: June 25, 2025
    Update
  15. Encompass Health reports results for first quarter 2025
    Results